Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?
- 1 February 2007
- journal article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 80 (950), 73-76
- https://doi.org/10.1259/bjr/17111243
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?Clinical Radiology, 2006
- Editorials: Nephrogenic Systemic Fibrosis: An Emerging Threat Among Renal PatientsSeminars in Dialysis, 2006
- Comparison of Gd(DTPA-BMA) (Omniscan) Versus Gd(HP-DO3A) (ProHance) Relative to Gadolinium Retention in Human Bone Tissue by Inductively Coupled Plasma Mass SpectroscopyInvestigative Radiology, 2006
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?Nephrology Dialysis Transplantation, 2006
- Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failureNephrology Dialysis Transplantation, 2004
- Zinc deficiencyBMJ, 2003
- Dialysis and contrast mediaEuropean Radiology, 2002
- Human In Vivo Comparative Study of Zinc and Copper Transmetallation After Administration of Magnetic Resonance Imaging Contrast AgentsInvestigative Radiology, 1996